These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 26331797)
1. Abnormal expression of miR-1 in breast carcinoma as a potent prognostic factor. Minemura H; Takagi K; Miki Y; Shibahara Y; Nakagawa S; Ebata A; Watanabe M; Ishida T; Sasano H; Suzuki T Cancer Sci; 2015 Nov; 106(11):1642-50. PubMed ID: 26331797 [TBL] [Abstract][Full Text] [Related]
2. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer. Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574 [TBL] [Abstract][Full Text] [Related]
3. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features. Wang B; Li J; Sun M; Sun L; Zhang X IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313 [TBL] [Abstract][Full Text] [Related]
4. Role of miR-139 as a surrogate marker for tumor aggression in breast cancer. Dai H; Gallagher D; Schmitt S; Pessetto ZY; Fan F; Godwin AK; Tawfik O Hum Pathol; 2017 Mar; 61():68-77. PubMed ID: 27864119 [TBL] [Abstract][Full Text] [Related]
5. Prognostic and biological significance of microRNA-127 expression in human breast cancer. Wang S; Li H; Wang J; Wang D; Yao A; Li Q Dis Markers; 2014; 2014():401986. PubMed ID: 25477702 [TBL] [Abstract][Full Text] [Related]
6. Effects of differential distribution of microvessel density, possibly regulated by miR-374a, on breast cancer prognosis. Li JY; Zhang Y; Zhang WH; Jia S; Kang Y; Tian R Asian Pac J Cancer Prev; 2013; 14(3):1715-20. PubMed ID: 23679262 [TBL] [Abstract][Full Text] [Related]
7. miR-125a-5p is a prognostic biomarker that targets HDAC4 to suppress breast tumorigenesis. Hsieh TH; Hsu CY; Tsai CF; Long CY; Chai CY; Hou MF; Lee JN; Wu DC; Wang SC; Tsai EM Oncotarget; 2015 Jan; 6(1):494-509. PubMed ID: 25504437 [TBL] [Abstract][Full Text] [Related]
8. Biological and prognostic associations of miR-205 and let-7b in breast cancer revealed by in situ hybridization analysis of micro-RNA expression in arrays of archival tumour tissue. Quesne JL; Jones J; Warren J; Dawson SJ; Ali HR; Bardwell H; Blows F; Pharoah P; Caldas C J Pathol; 2012 Jul; 227(3):306-14. PubMed ID: 22294324 [TBL] [Abstract][Full Text] [Related]
9. Expression and Tissue Distribution of MicroRNA-21 in Malignant and Benign Breast Tissues>. Hug KA; Anthony L; Eldeiry D; Benson J; Wheeler E; Mousa S; Shi B Anticancer Res; 2015 Jun; 35(6):3175-83. PubMed ID: 26026077 [TBL] [Abstract][Full Text] [Related]
10. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer. Dong LL; Chen LM; Wang WM; Zhang LM Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779 [TBL] [Abstract][Full Text] [Related]
11. High expression of miR-21 in tumor stroma correlates with increased cancer cell proliferation in human breast cancer. Rask L; Balslev E; Jørgensen S; Eriksen J; Flyger H; Møller S; Høgdall E; Litman T; Nielsen BS APMIS; 2011 Oct; 119(10):663-73. PubMed ID: 21917003 [TBL] [Abstract][Full Text] [Related]
12. Increased Brahma-related Gene 1 Expression Predicts Distant Metastasis and Shorter Survival in Patients with Invasive Ductal Carcinoma of the Breast. Do SI; Yoon G; Kim HS; Kim K; Lee H; Do IG; Kim DH; Chae SW; Sohn JH Anticancer Res; 2016 Sep; 36(9):4873-82. PubMed ID: 27630343 [TBL] [Abstract][Full Text] [Related]
13. Decreased expression of MicroRNA-200 family in human breast cancer is associated with lymph node metastasis. Xu F; He H; Huang W; Lin Y; Luo S; Du Q; Duan R Clin Transl Oncol; 2016 Mar; 18(3):283-8. PubMed ID: 26201425 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer. Gong C; Tan W; Chen K; You N; Zhu S; Liang G; Xie X; Li Q; Zeng Y; Ouyang N; Li Z; Zeng M; Zhuang S; Lau WY; Liu Q; Yin D; Wang X; Su F; Song E EBioMedicine; 2016 Sep; 11():199-209. PubMed ID: 27566954 [TBL] [Abstract][Full Text] [Related]
15. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1. Qian B; Katsaros D; Lu L; Preti M; Durando A; Arisio R; Mu L; Yu H Breast Cancer Res Treat; 2009 Sep; 117(1):131-40. PubMed ID: 18932017 [TBL] [Abstract][Full Text] [Related]
16. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression. Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789 [TBL] [Abstract][Full Text] [Related]
17. Decreased expression of microRNA-206 in breast cancer and its association with disease characteristics and patient survival. Li Y; Hong F; Yu Z J Int Med Res; 2013 Jun; 41(3):596-602. PubMed ID: 23696595 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma. Huang GL; Zhang XH; Guo GL; Huang KT; Yang KY; Shen X; You J; Hu XQ Oncol Rep; 2009 Mar; 21(3):673-9. PubMed ID: 19212625 [TBL] [Abstract][Full Text] [Related]
19. In situ hybridization analysis of the expression of miR-106b in colonic cancer. Wang YX; Lang F; Liu YX; Yang CQ; Gao HJ Int J Clin Exp Pathol; 2015; 8(1):786-92. PubMed ID: 25755775 [TBL] [Abstract][Full Text] [Related]
20. Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma. Guan Y; Chen L; Bao Y; Pang C; Cui R; Li G; Liu J; Wang Y Int J Clin Exp Pathol; 2015; 8(1):727-34. PubMed ID: 25755767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]